Related Experiment Videos
Duration of treatment for urinary tract infections in children
Insights
A six-month antibiotic course for pediatric urinary tract infections (UTIs) showed no significant advantage over a two-week treatment. Most reinfections occurred within five months of stopping antibiotics, suggesting limited long-term benefit from extended treatment.
Area of Science:
- Pediatric infectious diseases
- Pharmacology
- Urology
Background:
- Urinary tract infections (UTIs) are common in children.
- Recurrent UTIs pose a significant challenge in pediatric care.
- Antibiotic treatment duration for pediatric UTIs is a key consideration.
Purpose of the Study:
- To compare the efficacy of a six-month co-trimoxazole treatment versus a two-week course for children with Escherichia coli UTIs.
- To evaluate the long-term outcomes and recurrence rates following different treatment durations.
Main Methods:
- A double-blind, randomized trial involving 45 children (6 months to 14 years) with Escherichia coli UTIs.
- Participants received initial two-week co-trimoxazole treatment, then randomized to six months of active drug or placebo.
- Follow-up assessed infection recurrence for at least one year.
Main Results:
- 11 of 24 children (two-week group) and 10 of 21 children (six-month group) remained infection-free for at least a year.
- Over 90% of reinfections occurred within five months of antibiotic cessation.
- Extended treatment did not delay the appearance of reinfections.
Conclusions:
- A six-month co-trimoxazole course is unlikely to be more effective than a two-week course for achieving a long-term cure in pediatric UTIs.
- No infections occurred during the six-month treatment period.
- Continuous low-dose antibiotic therapy may offer some advantage during treatment, though long-term recurrence rates are similar.
Abstract:
In a double-blind trial 45 children aged 6 months to 14 years with Escherichia coli infections of the urinary tract were given co-trimoxazole for two weeks and then allotted at random to one of two treatment groups for the remainder of six months; one continued with the active drug and the other with dummy tablets of identical appearance. Of the 24 children who took co-trimoxazole for two weeks and the 21 who took it for six months, 11 and 10, respectively, remained without further infections for at least a year. Over 90% of the reinfections occurred within five months of stopping the antibiotics, and the longer treatment did not cause any delay in their appearance. Thus probably a six-month course of treatment is no more likely to achieve a cure than a two-week course; nevertheless, no infection occurred during treatment, and there may be an advantage in continuing with antibiotics in small dosage.